Seeking Alpha

Johnson & Johnson (JNJ) could face a massive fine after an Arkansas jury yesterday found the...

Johnson & Johnson (JNJ) could face a massive fine after an Arkansas jury yesterday found the company and its Janssen unit guilty of engaging in "false or deceptive acts" about the risks of the antipsychotic drug Risperdal, and of breaking consumer laws. It's not the first case J&J has lost over Risperdal. Arkansas is seeking $1.25B in fines. (previous)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|